CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP
Lili Ju(National Institutes of Health), Thomas A. Waldmann(National Institutes of Health)
Cited by 71
Related Papers
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
|Journal of Clinical Oncology|2014|698
Cytokines in Cancer Immunotherapy
|Cold Spring Harbor Perspectives in Biology|2017|509
The Shared and Contrasting Roles of IL2 and IL15 in the Life and Death of Normal and Neoplastic Lymphocytes: Implications for Cancer Therapy
|Cancer Immunology Research|2015|236
Approximations of a Ginzburg-Landau model for superconducting hollow spheres based on spherical centroidal Voronoi tessellations
|Mathematics of Computation|2004|34